Acceptability of cannabidiol as a treatment for people at clinical high risk for psychosis. - Oliver D; Chesney E; Wallman P; Estradé A; Azis M; Provenzani U; Damiani S; Melillo A; Hunt O; Agarwala S; Minichino A; Uhlhaas PJ; et al. (Frontiers in psychiatry, 2026)